Ilex Medical Statistics

Total Valuation

Ilex Medical has a market cap or net worth of ILS 730.76 million. The enterprise value is 522.24 million.

Market Cap	730.76M
Enterprise Value	522.24M

Important Dates

The next estimated earnings date is Monday, November 25, 2024.

Earnings Date	Nov 25, 2024
Ex-Dividend Date	n/a

Share Statistics

Ilex Medical has 11.28 million shares outstanding. The number of shares has decreased by -0.10% in one year.

Current Share Class	n/a
Shares Outstanding	11.28M
Shares Change (YoY)	-0.10%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	61.94%
Owned by Institutions (%)	17.29%
Float	3.00M

Valuation Ratios

The trailing PE ratio is 14.32.

PE Ratio	14.32
Forward PE	n/a
PS Ratio	0.75
PB Ratio	1.15
P/TBV Ratio	n/a
P/FCF Ratio	15.14
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.51, with an EV/FCF ratio of 10.82.

EV / Earnings	10.29
EV / Sales	0.54
EV / EBITDA	5.51
EV / EBIT	8.55
EV / FCF	10.82

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.08.

Current Ratio	2.62
Quick Ratio	1.87
Debt / Equity	0.08
Debt / EBITDA	0.53
Debt / FCF	1.10
Interest Coverage	34.50

Financial Efficiency

Return on equity (ROE) is 8.24% and return on invested capital (ROIC) is 6.22%.

Return on Equity (ROE)	8.24%
Return on Assets (ROA)	4.24%
Return on Capital (ROIC)	6.22%
Revenue Per Employee	4.33M
Profits Per Employee	227,552
Employee Count	223
Asset Turnover	0.99
Inventory Turnover	4.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.43% in the last 52 weeks. The beta is -0.10, so Ilex Medical's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	+8.43%
50-Day Moving Average	6,347.94
200-Day Moving Average	6,366.16
Relative Strength Index (RSI)	53.85
Average Volume (20 Days)	3,911

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ilex Medical had revenue of ILS 964.54 million and earned 50.74 million in profits. Earnings per share was 4.53.

Revenue	964.54M
Gross Profit	227.62M
Operating Income	66.32M
Pretax Income	68.25M
Net Income	50.74M
EBITDA	100.07M
EBIT	66.32M
Earnings Per Share (EPS)	4.53

Full Income Statement

Balance Sheet

The company has 261.83 million in cash and 53.31 million in debt, giving a net cash position of 208.52 million or 18.48 per share.

Cash & Cash Equivalents	261.83M
Total Debt	53.31M
Net Cash	208.52M
Net Cash Per Share	18.48
Equity (Book Value)	628.76M
Book Value Per Share	56.15
Working Capital	439.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 82.09 million and capital expenditures -33.84 million, giving a free cash flow of 48.26 million.

Operating Cash Flow	82.09M
Capital Expenditures	-33.84M
Free Cash Flow	48.26M
FCF Per Share	4.28

Full Cash Flow Statement

Margins

Gross margin is 23.60%, with operating and profit margins of 6.88% and 5.26%.

Gross Margin	23.60%
Operating Margin	6.88%
Pretax Margin	7.08%
Profit Margin	5.26%
EBITDA Margin	10.37%
EBIT Margin	6.88%
FCF Margin	5.00%

Dividends & Yields

This stock pays an annual dividend of 1.36, which amounts to a dividend yield of 2.10%.

Dividend Per Share	1.36
Dividend Yield	2.10%
Dividend Growth (YoY)	-28.80%
Years of Dividend Growth	n/a
Payout Ratio	30.08%
Buyback Yield	0.10%
Shareholder Yield	2.20%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.

Last Split Date	Aug 21, 2000
Split Type	Forward
Split Ratio	9

Scores

Ilex Medical has an Altman Z-Score of 3.67.

Altman Z-Score	3.67
Piotroski F-Score	n/a